DIFFERENT H2 RECEPTOR ANTIHISTAMINES DISSIMILARLY RETARD THE GROWTH OF XENOGRAFTED HUMAN MELANOMA CELLS IN IMMUNODEFICIENT MICE

Authors


To whom correspondence should be addressed: Tel.: (36)-1-210-2929; Fax: (36)-1-303-6968; E-mail: faland@dgci.sote.hu

Abstract

Melanoma cells and tissues contain considerable amounts of histamine and express histamine receptors, suggesting the existence of autocrine and paracrine regulation by histamine. Our previous in vitro results suggested that histamine elevates melanoma cell growth through the H2 receptor. In this work we show that in vivo tumour proliferation in immunodeficient mice xenotransplanted with a human melanoma cell line is diminished by cimetidine, an H2 receptor antagonist, if combined with a tamoxifen derivate acting on cytochrome p450 molecules (DPPE). Ranitidine, another H2 receptor antagonist, has a weaker inhibitory effect, the kinetics and mechanism of which is probably dissimilar to that of the cimetidine/DPPE mixture.

Ancillary